veratrine
Trade name: Unitensin
Small moleculeapproved
Approved
Jun 1, 1953
Cryptenamine (Unitensen) is a mixture of 10 hypotensive alkaloids extracted from Veratrum album. It is a hypotensive and used in the treatment of hypertension. — Wikipedia
Clinical trial activity
0 trials · 0 clinical orgs · 2 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1950s
- Jun 1, 1953
Irwin Neisler, & Company — Earliest FDA Approval
- Jun 1, 1953
Irwin Neisler, & Company — NDA Organization
Indications
Approved for
Mechanism of action
- Unspecified targetOTHER
Unknown
Approval history
- approvedJun 1, 1953
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Discontinued
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaCryptenamine ↗
- NCATSQVO4N8484O ↗
- ChEMBLCHEMBL1201603 ↗
- ChEMBLCHEMBL1201444 ↗
Also known as
- cryptenamine
- cryptenamine
- cryptenamine
- cryptenamine acetates
- cryptenamine acetates
- cryptenamine tannates
- cryptenamine tannates
- unitensen
- unitensen
- unitensin
- veratrine
- veratrine
Organizations
Marketing (2)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Irwin Neisler, & Company | For profit | NDA | Jun 1, 1953 |
| Medpointe | For profit | NDA2 | — |